AblivaListed
No domain yetbiotech_life_sciences
Abliva develops medicines for the treatment of mitochondrial disease, focusing on improving mitochondrial health through research and development of orphan drugs.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Abliva develops medicines for the treatment of mitochondrial disease, focusing on improving mitochondrial health through research and development of orphan drugs.
Actithera is a biotech company focused on developing targeted radioligand therapies for cancer, aiming to deliver personalized treatments with fewer side effects.
Alex Therapeutics is a Swedish digital health company that collaborates with pharmaceutical partners to support people facing treatment- and disease-related mental health challeng…
Attgeno AB, home of Supernitro, is a Swedish clinical stage pharmaceutical company developing innovative nitric oxide (NO)-donating technology and products, with a focus on treati…
CardioMech is focused on developing a catheter-based therapy for Mitral Regurgitation, an important cardiovascular condition. Their device aims to reduce or eliminate regurgitatio…
Cardior Pharmaceuticals is a pioneering biopharmaceutical company focused on discovering and developing RNA-based therapeutics to address the root causes of heart disease. Their m…
Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for complement-mediated diseases, focusing initially on geographic atrophy, an adva…
Contineum Therapeutics is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for neuroscience, inflammation and immunology indications with…
Emergence Therapeutics operates as a biopharmaceutical company. It develops novel antibody-drug conjugate (ADC) therapeutics to treat high-need cancers.
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibros…
Neuro Event Labs is a digital health technology company specializing in software-driven solutions for the diagnosis and monitoring of epilepsy and other neurological disorders, ut…
Nisonic AS is a medical software company developing products for non-invasive detection of intracranial pressure (ICP) using ultrasound imaging and machine learning.
Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients. Radspherin®, the compa…
Ribbon Bio specializes in cell-free synthetic DNA production, offering solutions that eliminate the need for bacterial cloning and streamline the workflow for complex DNA synthesi…
SAGA Diagnostics is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence. Their flagship product,…
SciRhom GmbH is a pioneering biotech enterprise focused on developing first-in-class humanized antibodies against iRhom2 for the treatment of autoimmune diseases, including rheuma…
Themis Bioscience developed vaccines for infectious diseases using a proprietary measles virus vector-based platform technology. This innovative approach enabled the creation of i…
Kasvu Therapeutics is a drug development company focused on creating non-hallucinogenic small molecules to treat neuropsychiatric and neurodegenerative disorders, leveraging neuro…
TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED’s unique biolo…
STEP Pharma is a biotechnology company focused on developing targeted cancer therapies, particularly through the inhibition of CTPS1. Their lead asset, dencatistat, is in clinical…
ARTHEx Biotech is a clinical-stage biotechnology company focused on developing RNA-based therapeutics targeting neuromuscular disorders, particularly Myotonic Dystrophy Type 1.
Gesynta Pharma is a clinical stage pharmaceutical company developing innovative treatments by targeting mPGES-1, an important pro-inflammatory enzyme with a key role in endometrio…